Peter Hauff Selected Research

Peter Hauff Research Topics

Disease

16	Neoplasms (Cancer) 06/2014 - 03/2002
3	Neoplasm Metastasis (Metastasis) 10/2010 - 06/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2011 - 09/2003
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2010 - 01/2008
2	Breast Neoplasms (Breast Cancer) 06/2009 - 03/2002
1	Mesothelioma 06/2014
1	Adenocarcinoma of Lung 06/2014
1	Lymphatic Metastasis 10/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2010
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2010
1	Vascular Remodeling 01/2010
1	Disease Progression 01/2010
1	Prostatic Neoplasms (Prostate Cancer) 09/2009
1	Paraplegia (Spastic Paraplegia) 06/2009
1	Cachexia 06/2009
1	Bone Resorption 06/2009
1	Teratocarcinoma 12/2008
1	Atherosclerosis 03/2008
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2005

Drug/Important Bio-Agent (IBA)

3	Contrast MediaIBA 01/2008 - 12/2002
2	Angiopoietin-2IBA 10/2011 - 01/2010
2	LuciferasesIBA 10/2010 - 05/2010
2	Biological ProductsIBA 01/2010 - 09/2003
2	LigandsIBA 01/2010 - 01/2008
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2009 - 11/2005
1	Immunoconjugates (Immunoconjugate)IBA 06/2014
1	MesothelinIBA 06/2014
1	anetumab ravtansineIBA 06/2014
1	Differentiation AntigensIBA 06/2014
1	Vascular Endothelial Growth Factor CIBA 10/2011
1	Biomarkers (Surrogate Marker)IBA 10/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2011
1	Vascular Endothelial Growth Factor DIBA 10/2011
1	Tyrosine (L-Tyrosine)FDA Link 10/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2010
1	Messenger RNA (mRNA)IBA 01/2010
1	IonsIBA 09/2009
1	CarbonIBA 09/2009
1	Epothilones (Epothilone)IBA 06/2009
1	sagopiloneIBA 06/2009
1	AcidsIBA 02/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2009
1	Coloring Agents (Dyes)IBA 12/2008
1	CholesterolIBA 03/2008
1	ApolipoproteinsIBA 03/2008
1	Apolipoproteins E (ApoE)IBA 03/2008
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2008
1	Ezetimibe (Zetia)FDA Link 03/2008
1	1,1'- bis- (4- sulfobutyl)indotricarbocyanine- 5,5'- dicarboxylic acid diglucamideIBA 01/2008
1	Integrin alphaVbeta3IBA 01/2008
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2008
1	CyanoacrylatesIBA 01/2008
1	Matrix Metalloproteinase InhibitorsIBA 01/2008
1	Myelin Basic ProteinIBA 11/2005
1	DNA (Deoxyribonucleic Acid)IBA 08/2005
1	Therapeutic UsesIBA 08/2005
1	beta-Galactosidase (Lactaid)IBA 08/2005
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2003

Therapy/Procedure

4	Therapeutics 06/2014 - 01/2008
4	Microbubbles 07/2010 - 01/2008
1	Intravenous Infusions 08/2005
1	Radiofrequency Ablation 12/2002
1	Electrodes (Electrode) 03/2002